Amid preparations to stamp its passport on the American capital market, by dual-listing its shares on the New York Stock Exchange and B3, JBS reinforced the presence of a relevant shareholder in its captable.
On the evening of Wednesday, January 31, the company released a statement informing that Capital Research Global Investors increased the stake it manages in common shares issued by the company, from 4.97% to 5.02%.
In the correspondence sent to JBS, the American manager informed that the increase in the stake is a minority investment that does not change the composition of control or the administrative structure of the Brazilian group.
Although the increase in participation does not initially appear significant, it is in line with the dual listing process and meets JBS’s intention to bring more foreign institutional investors to its shareholder base.
In this case, Capital Research Global Investors brings to the table an operation founded in 1931 and with US$2.3 trillion in assets under management. And it already has proximity to the Brazilian market, having stakes in companies such as Vale
Access to the pockets of global investors, based on this path, directly relates to the fact that, today, a large part of JBS’s results also come from abroad. In the third quarter of 2023, international operations accounted for 74.3% of total revenue of R$91.4 billion.
JBS shares closed this Wednesday’s trading session with a drop of 0.42%, quoted at R$23.43. During the year, the shares accumulated a devaluation of 5.9%, taking the company’s market value to the level of R$52 billion.